News
The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...
Novo Nordisk and GoodRx announced a partnership this week to sell products Ozempic and Wegovy at half their normal cost to ...
Novo Nordisk lowers Ozempic cost to $499 per month for uninsured U.S. patients, expanding access through NovoCare and 70,000 ...
Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.
(CNN)– Patients in the U.S. can now get Ozempic for half the price, if they pay in cash. Novo Nordisk, the maker of the diabetes drug announced Monday, Aug. 19, that U.S. patients can now get a ...
Novo said cash-paying Americans can now buy Ozempic for $499 per month through various channels including its official ...
Novo Nordisk reduces Ozempic's price to $499/month for self-paying patients, enhancing access to essential diabetes treatment ...
Novo Nordisk revealed on Monday that US patients can now receive a month’s supply of Ozempic, a highly effective diabetes ...
Diabetic medicine Ozempic now approved by Health Canada to reduce the risk of further kidney decline among patients with Type ...
After Novo Nordisk revealed Ozempic will retail for half-price at 70,000 pharmacies throughout the US, people are questioning ...
Canada has approved Novo Nordisk's diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of ...
InvestorsHub on MSN13h
Novo Nordisk’s Ozempic Secures Canadian Approval for Kidney Disease Use
Novo Nordisk (NYSE:NVO) said Tuesday that Health Canada has expanded the label for its diabetes therapy Ozempic, granting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback